Carisma Therapeutics Inc. (CARM)
0.44
-0.01 (-3.25%)
At close: Jan 15, 2025, 3:55 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -1.13 | -0.02 | -3.64 | -5.64 | -0.88 | -2.6 | -0.73 | 21.29 | -1.71 | -5.04 | -4.77 | -3.9 | -7.14 |
| PS Ratio | 6.58 | 0.13 | 5.60 | 14.20 | n/a | n/a | 49.81 | 1.34 | 57.75 | 77.56 | 69.45 | n/a | n/a |
| PB Ratio | 3.70 | -0.03 | 12.78 | 4.46 | -3.54 | 1.98 | 1.17 | 1.04 | 3.02 | 4.72 | 39.49 | 13.46 | -630.26 |
| P/FCF Ratio | -1.19 | -0.11 | -3.79 | -5.81 | -2.51 | -3.84 | -1.19 | 15.36 | -1.64 | -5.91 | -6.87 | -4.02 | -7.94 |
| P/OCF Ratio | -1.21 | -0.17 | -3.98 | -5.91 | -2.52 | -3.84 | -1.19 | 15.36 | -1.66 | -5.94 | -6.87 | -4.05 | -8.52 |
| OCF/S Ratio | -5.44 | -0.77 | -1.41 | -2.4 | n/a | n/a | -41.8 | 0.09 | -34.88 | -13.07 | -10.12 | n/a | n/a |
| Debt / Equity Ratio | 0.12 | -0.82 | 0.23 | 0.10 | n/a | n/a | n/a | n/a | 0.73 | 0.27 | 1.93 | 0.35 | -7 |
| Quick Ratio | 5.06 | 2.82 | 7.06 | 9.34 | 6.39 | 8.47 | 3.17 | 6.51 | 4.79 | 10.46 | 1.50 | 4.53 | 0.45 |
| Current Ratio | 5.06 | 2.78 | 3.87 | 9.34 | 6.39 | 8.47 | 3.17 | 6.51 | 4.79 | 10.46 | 1.50 | 4.53 | 0.45 |
| Asset Turnover | 0.17 | 0.14 | 0.75 | 0.19 | n/a | n/a | 0.01 | 0.29 | 0.03 | 0.04 | 0.12 | n/a | n/a |
| Interest Coverage | n/a | -17.86 | n/a | n/a | n/a | n/a | n/a | 24.96 | -25.23 | -89.84 | -11.88 | -116.01 | -83.94 |
| Return on Equity (ROE) | -3.27 | 1.24 | -3.51 | -0.79 | 4.03 | -0.76 | -1.61 | 0.05 | -1.77 | -0.94 | -8.28 | -3.45 | 88.28 |
| Return on Assets (ROA) | -0.97 | -0.85 | -1.15 | -0.48 | -0.94 | -0.3 | -0.39 | 0.02 | -0.91 | -0.63 | -1.73 | -2.09 | -4.87 |
| Return on Capital (ROIC) | -1.2 | -1.07 | -1.47 | -0.54 | -0.35 | -0.24 | -0.28 | 0.06 | -1.2 | -0.68 | -2.83 | -2.54 | -28.36 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -396.85% | 38.07% | 99.68% | 100.00% | n/a | n/a | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | n/a | n/a |
| Net Profit Margin | -582.34% | -622.6% | -153.61% | -252.05% | n/a | n/a | -6.83K% | 6.31% | -3.38K% | -1.54K% | -1.46K% | n/a | n/a |
| Pretax Profit Margin | -582.34% | -622.6% | -153.65% | -252.31% | n/a | n/a | -6.83K% | 6.32% | -3.38K% | -1.52K% | -1.35K% | n/a | n/a |
| Operating Profit Margin | -594.75% | -571.1% | -153.68% | -252.56% | n/a | n/a | -4.70K% | 20.57% | -3.56K% | -1.51K% | -1.25K% | n/a | n/a |
| FCF Margin | -551.71% | -124.32% | -147.68% | -244.32% | n/a | n/a | -4.18K% | 8.75% | -3.52K% | -1.31K% | -1.01K% | n/a | n/a |
| EBITDA Margin | -575.74% | -528.69% | -151.12% | -248.58% | n/a | n/a | -6.76K% | 7.74% | -3.20K% | -1.49K% | -1.29K% | n/a | n/a |